Logo image
Back
Alterations of CXCR4 function in μ-opioid receptor-deficient glia
Journal article   Open access   Peer reviewed

Alterations of CXCR4 function in μ-opioid receptor-deficient glia

Silvia Burbassi, Rajarshi Sengupta and Olimpia Meucci
The European journal of neuroscience, v 32(8), pp 1278-1288
Oct 2010
DOI: https://doi.org/10.1111/j.1460-9568.2010.07402.x
PMID: 20880358
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1111/j.1460-9568.2010.07402.xView
Published, Version of Record (VoR) Open

Abstract

Receptors, Opioid, delta - metabolism Immunoprecipitation Signal Transduction Receptors, Opioid, mu - metabolism Cells, Cultured Extracellular Signal-Regulated MAP Kinases - metabolism Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Mice, Knockout Receptors, CXCR4 - metabolism Brain - metabolism Animals Neuroglia - metabolism Mice Neurons - metabolism Receptors, Opioid, mu - genetics Proto-Oncogene Proteins c-akt - metabolism
The chemokine receptor CXCR4 and the μ-opioid receptor (MOR) are G-protein-coupled receptors that are essential for normal function of the nervous and immune systems. Several studies have suggested that MOR is a key regulator of CXCR4 in the brain; however, the molecular basis of the opioid-chemokine interaction is not fully understood, and it may involve different mechanisms in neuronal and glial cells. Our previous studies demonstrated that MOR stimulation specifically upregulates the protein ferritin heavy chain - an inhibitor of CXCR4 - in neurons, and suggested that additional mechanisms could be operative in glia. In this study, we investigated CXCR4 function in brains and astroglial cultures deprived of MOR. Reduced coupling of CXCR4 to G-proteins was found in brain slices and tissue homogenates of MOR(-/-) mice as compared with wild-type controls. CXCR4-induced signaling was also reduced in glial cultures from MOR(-/-) mice, as shown by analysis of CXCR4 downstream targets (Akt and ERK1/2). Pharmacological studies with δ-opioid receptor (DOR)-specific ligands suggested that DOR-CXCR4 interactions are implicated in the inhibition of CXCR4 in MOR-deficient cells both in vitro and in vivo. Moreover, increased CXCR4/DOR co-immunoprecipitation was found in brain tissue and cultured glia from MOR(-/-) mice. Importantly, CXCR4 function was restored by pretreatment with a DOR antagonist. Overall, these findings indicate that DOR plays a crucial role in the regulation of CXCR4 in glia, probably via silent receptor heterodimers. The data also suggest that the opiate system interferes with normal CXCR4 function in different ways, depending on receptor subtypes.

Metrics

12 Record Views
24 citations in Web of Science
24 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Neurosciences
Logo image